Recent Posts
Biologicals
How to Build an Indian Regulatory Strategy for Advanced Biologicals Before Entering the Market
The decision to enter the Indian market with an advanced Biological product should be made with a comprehensive regulatory strategy in place. India’s multi-authority regulatory environment, dist..
Pharmaceutical | Drug | Medical Device
AI in Regulatory Affairs and Clinical Development: What Pharmaceutical Companies Need to Know in 2026
Artificial intelligence is reshaping Pharmaceutical research and development, regulatory affairs, and clinical operations at a pace that few industries have previously experienced. From AI-accelerated..
Cosmetic
India as a Cosmetic Manufacturing Hub: CDSCO, BIS, and the Regulatory Enablers for Global Manufacturers
The Strategic Shift For most global Cosmetic brands, India’s regulatory journey has begun with import registration — the COS-2 pathway explored throughout this series. But for a growing ..
Need Help?
Submit your EnquiryOffice Locations
- Delhi
- Bangalore
- USA
- Singapore